AGIANA PHARMACEUTICALS AS
Organization
- CEO
- RI
- Chairman of the board
- TR
Thomas Ramdahl1956
- Years since formation
- 4 years
- since Sep 3, 2021
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 36,050
- 1 share class
- Total number of shareholders
- 4
- 1 company, 3 persons
Financials
- Total operating income 2024
- 534,593
- NOK
- Annual total result 2024
- -4,501,218
- NOK
- Total equity 2024
- 13,418,303
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
RI | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
TR 1956 | Chairman | - |
| Board Member | - | |
AP | Board Member | - |
JD | Board Member | - |
TJ | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
SJ 1985 | - | 8.32 % directly |
JM | - | 5.55 % directly |
Last update: Oct 14, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 17,686 | 49.06 % | |
| Ordinary shares | 13,364 | 37.07 % | |
SJ 1985 | Ordinary shares | 3,000 | 8.32 % |
JM | Ordinary shares | 2,000 | 5.55 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 534,593 | 235,252 | 0 | 0 |
Annual Total Result | -4,501,218 | -2,946,196 | -2,958,933 | 0 |
Total assets | 14,142,297 | 1,680,930 | 4,226,158 | 30,000 |
Total liabilities | 723,994 | 7,556,059 | 7,155,091 | 0 |
Total equity | 13,418,303 | -5,875,129 | -2,928,933 | 30,000 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 534,593 | 235,252 | 0 | 0 |
Total operating costs | 5,194,803 | 2,870,809 | 2,845,924 | 0 |
Operating result | -4,660,210 | -2,635,557 | -2,845,924 | 0 |
Financial income/costs | 158,993 | -310,640 | -113,009 | 0 |
Profit before tax | -4,501,218 | -2,946,196 | -2,958,933 | 0 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -4,501,218 | -2,946,196 | -2,958,933 | 0 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 14,142,297 | 1,680,930 | 4,226,158 | 30,000 |
Total assets | 14,142,297 | 1,680,930 | 4,226,158 | 30,000 |
Short term debt | 723,994 | 466,059 | 429,535 | 0 |
Long term debt | 0 | 7,090,000 | 6,725,556 | 0 |
Total liabilities | 723,994 | 7,556,059 | 7,155,091 | 0 |
Contributed capital | 23,824,650 | 30,000 | 30,000 | 30,000 |
Retained earnings | -10,406,347 | -5,905,129 | -2,958,933 | 0 |
Total equity | 13,418,303 | -5,875,129 | -2,928,933 | 30,000 |
Total equity and liabilities | 14,142,297 | 1,680,930 | 4,226,158 | 30,000 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises